Halozyme Therapeutics

11388 Sorrento Valley Road Suite 200
San Diego,  CA  92121

United States
http://www.halozyme.com/
  • Booth: 2074

Halozyme, Inc. is a biotechnology company focused on developing and commercializing novel oncology therapies that target the tumor microenvironment. Halozyme’s lead proprietary program, investigational drug PEGPH20, applies a unique approach to targeting solid tumors, allowing increased access of co-administered cancer drug therapies to the tumor in animal models. Halozyme has established partnerships with leading pharmaceutical companies including Roche, Baxalta, Pfizer, Janssen, AbbVie and Lilly for its ENHANZE™ drug delivery platform. Halozyme is headquartered in San Diego, California.


  •  
  •      
     

  •  
  •